Launch of New 18F-PSMA-1007 Production Line
S.R.Y. has successfully developed and implemented a production line for 18F-PSMA-1007, a novel fluorine-18 labeled PSMA (prostate specific membrane antigen) ligand
S.R.Y. has successfully developed and implemented a production line for 18F-PSMA-1007, a novel fluorine-18 labeled PSMA (prostate specific membrane antigen) ligand
The Ministry of Health has granted S.R.Y. a GMP certification for a radiopharmaceutical production line. As part of our core values,
S.R.Y. Medical Services is proud to announce, for the first time in Israel, the launch of 18F-NOTA-OCTREOTIDE, a somatostatin analog labeled
The human norepinephrine transporter (hNET) is a transmembrane protein responsible for the uptake of norepinephrine into noradrenergic synaptic terminals of the
A novel facility for the research and development of radiopharmaceuticals has been inaugurated in Hadassah Ein Kerem Hospital following a 13 million NIS investment. The facility is located four stories underground and has 2.5-meter-thick concrete walls.
New Radioactive Drug Production Rooms Inaugurated at Hadassah Ein Kerem Campus The most advanced rooms in Israel for developing and producing
In a secluded bunker located under Hadassah Ein-Kerem hospital resides an exceptional particle accelerator called “cyclotron”. Dror Foyer visited the sanctum sanctorum in an attempt to unveil the mysteries of radioactive drug (AKA radiopharmaceutical) production. Similar to guided missiles, these unique radiopharmaceuticals can target various pathologies but are most commonly used in cancer. Following their injection into patients, they enable imaging and/or treatment of various tumors.
For the first time: Brain imaging will identify the protein associated with the risk of suffering from the disease. The test
Hadassah has a six-year contract to exclusively produce and market Vizamyl. A new medical test that could help doctors prevent the
S.R.Y. (Specialized Medical Services) is an Israeli company that manufactures and develops radiopharmaceuticals for diagnosis, treatment and medical research. The company operates the cyclotron unit at Hadassah Ein Kerem Hospital and produces medical isotopes in an advanced nuclear pharmacy.
All information on this site is general only and should not be considered in any way medical advice, treatment recommendation, a substitute for treatment, or a recommendation for a pharmaceutical preparation. Therefore, the content and information should not be relied upon for the purpose of receiving or providing medical treatment, and the information is not a substitute for the instructions in the consumer leaflet or for consultation with a qualified medical professional.
S.R.Y. (Specialized Medical Services) strives to provide as up-to-date and reliable information as possible on this site, but does not guarantee the completeness or completeness of the information on the site. Any use of the information on the site is the sole responsibility of the users.
